Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model

Blood

Volumn 122, Issue 8, 2013, Pages 1494-1504

  Stowell, Sean R ^a   Henry, Kate L ^a   Smith, Nicole H ^a   Hudson, Krystalyn E ^a   Halverson, Greg R ^b   Park, Jaekeun C ^c   Bennett, Ashley M ^a   Girard Pierce, Kathryn R ^a   Arthur, C Maridith ^a   Bunting, Silvia T ^d   Zimring, James C ^e   Hendrickson, Jeanne E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^e PUGET SOUND BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIGEN; GLYCOPROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PATERNALLY DERIVED ERYTHROCYTE KEL ANTIGEN; UNCLASSIFIED DRUG; CYTOKINE; GREEN FLUORESCENT PROTEIN;

AGAMMAGLOBULINEMIA; ALLOIMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP INCOMPATIBILITY; CLEARANCE; CONTROLLED STUDY; COOMBS TEST; CYTOKINE STORM; ERYTHROCYTE TRANSFUSION; FEMALE; FETUS; FETUS LIVER; HEMOLYTIC ANEMIA; LITTER SIZE; MALE; MATERNAL AGE; MATING; MOUSE; NEWBORN; NEWBORN ANEMIA; NONHUMAN; PLACENTA; PRECURSOR; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIMIGRAVIDA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BLOOD GROUP KELL SYSTEM; BLOOD TRANSFUSION; BREEDING; C57BL MOUSE; CYTOLOGY; ERYTHROCYTE; GENETICS; IMMUNOLOGY; METABOLISM; TRANSGENIC MOUSE;

ANEMIA, HEMOLYTIC; ANIMALS; BLOOD TRANSFUSION; CYTOKINES; ERYTHROCYTES; FEMALE; GREEN FLUORESCENT PROTEINS; IMMUNOGLOBULIN G; ISOANTIBODIES; KELL BLOOD-GROUP SYSTEM; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; PREGNANCY; PREGNANCY, ANIMAL;

EID: 84886809808     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-03-488874     Document Type: Article

References (40)

1. Reid ME, Mohandas N. Red blood cell blood group antigens: structure and function. Semin Hematol. 2004;41(2):93-117.
2. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book, 2nd ed. Amsterdam: Elsevier Academic Press; 2004.
3. Heard DH, Hinde IT, Mynors LS. An experimental study of haemolytic disease of the newborn due to isoimmunization of pregnancy. J Hyg (Lond). 1949;47(2):119-131.
4. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2002;100(3):600-611.
5. Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med. 2008;13(4):207-214.
6. Harper DC, Swingle HM, Weiner CP, Bonthius DJ, Aylward GP, Widness JA. Long-term neurodevelopmental outcome and brain volume after treatment for hydrops fetalis by in utero intravascular transfusion. Am J Obstet Gynecol. 2006;195(1):192-200.
7. van Klink JM, Koopman HM, Oepkes D, Walther FJ, Lopriore E. Long-term neurodevelopmental outcome after intrauterine transfusion for fetal anemia. Early Hum Dev. 2011;87(9):589-593.
8. Kumpel BM. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin Exp Immunol. 2008; 154(1):1-5.
9. Kumpel BM. Monoclonal anti-D development programme. Transpl Immunol. 2002;10(2-3): 199-204.
10. Kumpel BM. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers. Vox Sang. 2007;93(2): 99-111.
11. Coombs RR, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet. 1946;1(6391): 264-266.
12. Ottensooser F, Mellone O, Blancalana A. Fatal transfusion reaction due to the Kell factor. Blood. 1953;8(11):1029-1033.
13. Westhoff CM, Reid ME. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematol. 2004;20(1):37-49.
14. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S. Maternal Kell blood group alloimmunization. Obstet Gynecol. 1992;79(2): 239-244.
15. Eder AF. Update on HDFN: new information on long-standing controversies. Immunohematol. 2006;22(4):188-195.
16. Rimon E, Peltz R, Gamzu R, et al. Management of Kell isoimmunization—evaluation of a Doppler-guided approach. Ultrasound Obstet Gynecol. 2006;28(6):814-820.
17. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med. 1998;338(12): 798-803.
18. Vaughan JI, Warwick R, Welch CR, Letsky EA. Anti-Kell in pregnancy. Br J Obstet Gynaecol. 1991;98(9):944-945.
19. Smith NH, Henry KL, Cadwell CM, Bennett A, Hendrickson JE, Frame T, Zimring JC. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion. 2012;52(12): 2620-2630.
20. Liepkalns JS, Cadwell CM, Stowell SR, Hod EA, Spitalnik SL, Zimring JC. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion. Transfusion. 2013;53(6):1319-1327.
21. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcg receptors in a murine model. Transfusion. 2012; 52(12):2631-2645.
22. Zimring JC, Cadwell CM, Spitalnik SL. Antigen loss from antibody-coated red blood cells. Transfus Med Rev. 2009;23(3):189-204.
23. Zimring JC, Hair GA, Chadwick TE, Deshpande SS, Anderson KM, Hillyer CD, Roback JD. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood. 2005;106(3): 1105-1112.
24. Pop R, Shearstone JR, Shen Q, et al. A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression. PLoS Biol. 2010;8(9):pii:e1000484.
25. Zhang J, Socolovsky M, Gross AW, Lodish HF. Role of Ras signaling in erythroid differentiation of mouse fetal liver cells: functional analysis by a flow cytometry-based novel culture system. Blood. 2003;102(12):3938-3946.
26. Townes TM, Lingrel JB, Chen HY, Brinster RL, Palmiter RD. Erythroid-specific expression of human beta-globin genes in transgenic mice. EMBO J. 1985;4(7):1715-1723.
27. Chen K, Liu J, Heck S, Chasis JA, An X, Mohandas N. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA. 2009; 106(41):17413-17418.
28. Liu J, Zhang J, Ginzburg Y, et al. Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. Blood. 2013;121(8):e43-e49.
29. Camara-Clayette V, Rahuel C, Lopez C, Hattab C, Verkarre V, Bertrand O, Cartron JP. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells. Biochem J. 2001; 356(Pt 1):171-180.
30. Stowell SR, Girard-Pierce KR, Smith NH, Henry KL, Arthur CM, Zimring JC, Hendrickson JE. Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies [published online ahead of print April 13, 2013]. Transfusion. doi: 10.1111/trf.12217.
31. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol. 1994;171(1):247-252.
32. Anderson JR. The experimental production of erythroblastosis foetalis in rabbits. Br J Haematol. 1956;2(1):44-60.
33. Kellner A, Hedal EF. Experimental erythroblastosis fetalis in rabbits. I. Characterization of a pair of allelic blood group factors and their specific immune isoantibodies. J Exp Med. 1953;97(1):33-49.
34. Moise KJ Jr, Rodkey LS, Saade GR, Duré M, Dorman K, Mayes M, Graham A. An animal model for hemolytic disease of the fetus and newborn. II. Fetal effects in New Zealand rabbits. Am J Obstet Gynecol. 1995;173(3 Pt 1):747-753.
35. Moise KJ Jr, Rodkey LS, Yared M, Hudon L, Saade G, Dorman K, Graham A. An animal model for hemolytic disease of the fetus or newborn in New Zealand white and New Zealand red rabbits: newborn effects. Am J Obstet Gynecol. 1998; 179(5):1353-1358.
36. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112(1):164-176.
37. Kumpel BM. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Transfusion. 2006;46(9):1652-1656.
38. Kumpel BM, Elson CJ. Mechanism of anti-D-mediated immune suppression—a paradox awaiting resolution? Trends Immunol. 2001;22(1): 26-31.
39. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol. 2013;31:387-411.
40. Mohanty S, Kim J, Ganesan LP, et al. IgG is transported across the mouse yolk sac independently of FcgammaRIIb. J Reprod Immunol. 2010;84(2):133-144.